학술논문
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study
Document Type
Article
Author
Roubaud, G.; Özgüroğlu, M.; Penel, N.; Matsubara, N.; Mehra, N.; Kolinsky, M.P.; Procopio, G.; Feyerabend, S.; Joung, J.Y.; Gravis, G.; Nishimura, K.; Gedye, C.; Padua, C.; Shore, N.; Thiery-Vuillemin, A.; Saad, F.; van Alphen, R.; Carducci, M.A.; Desai, C.; Brickel, N.; Del Rosario, P.; Poehlein, C.; Fizazi, K.
Source
In: European Journal of Cancer . (European Journal of Cancer, July 2022, 170:73-84)
Subject
Language
English
ISSN
18790852
09598049
09598049